RIDR-PI-103 is a reactive oxygen species (ROS)-induced agent release proagent with a self-cyclizing moiety linked to a pan-PI3K inhibitor (PI-103). Doxorubicin and RIDR-PI-103 shows a synergistic effect in MDA-MB-361 and MDA-MB-231 cells to inhibit cancer cell proliferation[1][2].
Molecular Weight:
511.53
Purity:
98.02
CAS Number:
[2581114-71-6]
Formula:
C27H25N7O4
Target:
Reactive Oxygen Species (ROS)
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
